IL-6 may contribute to the initiation, progression, and maintenance of hypertension by reducing nitric oxide bioavailability, increasing vascular oxidative stress, regulating angiotensin II expression, and altering vascular function and structure [55]. This evidence concerns the gene AGT and hypertensive disorder.